Spermidine/spermine N1-acetyltransferase specifically binds to the integrin α9 subunit cytoplasmic domain and enhances cell migration by Chen, Chun et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 167, No. 1, October 11, 2004 161–170
http://www.jcb.org/cgi/doi/10.1083/jcb.200312166
 
JCB: ARTICLE
 
JCB 161
 
Spermidine/spermine 
 
N
 
1
 
-acetyltransferase 
speciﬁcally binds to the integrin 
 
 
 
9 subunit 
cytoplasmic domain and enhances cell migration
 
Chun Chen,
 
1
 
 Bradford A. Young,
 
1
 
 Catherine S. Coleman,
 
2
 
 Anthony E. Pegg,
 
2
 
 and Dean Sheppard
 
1
 
1
 
Lung Biology Center, Department of Medicine, University of California, San Francisco, San Francisco, CA 94110
 
2
 
Department of Cellular and Molecular Physiology, College of Medicine, The Pennsylvania State University, Hershey, PA 17033
 
he integrin 
 
 
 
9
 
 
 
1 is expressed on migrating cells,
such as leukocytes, and binds to multiple ligands
that are present at sites of tissue injury and inﬂam-
mation. 
 
 
 
9
 
 
 
1, like the structurally related integrin 
 
 
 
4
 
 
 
1,
mediates accelerated cell migration, an effect that de-
pends on the 
 
 
 
9 cytoplasmic domain. 
 
 
 
4
 
 
 
1 enhances mi-
gration through reversible binding to the adapter protein,
paxillin, but 
 
 
 
9
 
 
 
1-dependent migration is paxillin inde-
pendent. Using yeast two-hybrid screening, we identiﬁed
the polyamine catabolizing enzyme spermidine/spermine
 
N
 
1
 
-acetyltransferase (SSAT) as a speciﬁc binding partner
T
 
of the 
 
 
 
9 cytoplasmic domain. Overexpression of SSAT
increased 
 
 
 
9
 
 
 
1-mediated migration, and small interfer-
ing RNA knockdown of SSAT inhibited this migration
without affecting cell adhesion or migration that was me-
diated by other integrin cytoplasmic domains. The en-
zyme activity of SSAT is critical for this effect, because a
catalytically inactive version did not enhance migration.
We conclude that SSAT directly binds to the 
 
 
 
9 cytoplas-
mic domain and mediates 
 
 
 
9-dependent enhancement of
cell migration, presumably by localized effects on acety-
lation of polyamines or of unidentiﬁed substrates.
 
Introduction
 
Cell migration is central to many biological and pathological
processes, including embryogenesis, inflammation, tissue repair
and regeneration, and cancer metastasis (Lauffenburger and
Horwitz, 1996). For cells to migrate on a substrate, they must ad-
here and de-adhere in a coordinated manner and generate tensile
force in the direction of migration. The force required to pro-
mote migration is generated by the actin cytoskeleton and the in-
tegrin-dependent protein complexes that anchor actin to specific
sites on the cell membrane (Lauffenburger and Horwitz, 1996).
Although several members of the integrin family can me-
diate cell migration, two structurally related integrin 
 
 
 
 sub-
units, 
 
 
 
4 and 
 
 
 
9, appear to play specialized roles in accelerated
migration. Several studies using chimeric integrin 
 
 
 
 subunits
have demonstrated that this enhancement of migration depends
on distinct sequences within the cytoplasmic domains of 
 
 
 
4
(Chan et al., 1992; Kassner and Hemler, 1993; Kassner et al.,
1995) and 
 
 
 
9 (Young et al., 2001). Integrin 
 
 
 
4–mediated cell
migration depends on the specific interaction of the 
 
 
 
4 cyto-
plasmic domain with the adapter protein paxillin (Liu et al.,
1999), and it requires the dissociation of paxillin from integrin
at the leading edge of migrating cells upon phosphorylation of
a specific serine at position 988 in the 
 
 
 
4 cytoplasmic domain
(Han et al., 2001; Goldfinger et al., 2003). The 
 
 
 
9 cytoplasmic
domain is 47% identical to the 
 
 
 
4 cytoplasmic domain, and
also binds paxillin (Young et al., 2001). However, 
 
 
 
9 does not
contain a homologous phosphorylation site; although the inter-
action between paxillin and 
 
 
 
9 is critical for the effects of the
integrin 
 
 
 
9
 
 
 
1 on cell spreading, this interaction is completely
dispensable for 
 
 
 
9-dependent enhancement of cell migration
(Young et al., 2001). Therefore, we used yeast two-hybrid
screening to identify proteins that interact with the 
 
 
 
9 cytoplas-
mic domain to mediate enhanced cell migration.
 
Results
 
Identification of SSAT as a specific 
binding partner of the integrin 
 
 
 
9 
subunit cytoplasmic domain
 
Proteins that interact with the 
 
 
 
9 cytoplasmic domain were iden-
tified by yeast two-hybrid screening of a human leukocyte cDNA
library, using the entire cytoplasmic domain of human 
 
 
 
9 (resi-
dues 974–1006) as bait. Several candidate cDNAs were isolated
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and sequenced. These candidates were rescreened by cotransfor-
mation with bait vectors containing the 
 
 
 
9, 
 
 
 
5, 
 
 
 
4, 
 
 
 
2, or 
 
 
 
1 cy-
toplasmic domains. Only a single candidate, human spermidine/
spermine 
 
N
 
1
 
-acetyltransferase (SSAT), was found to specifically
interact with 
 
 
 
9 and not with 
 
 
 
5, 
 
 
 
4, 
 
 
 
2, or 
 
 
 
1 (Fig. 1 a).
To confirm the results of the two-hybrid screen, and to
determine precisely which region(s) of SSAT interacted with
the 
 
 
 
9 cytoplasmic domain, we evaluated the binding of GST
fusion proteins containing the 
 
 
 
9, 
 
 
 
5, 
 
 
 
4, and 
 
 
 
2 cytoplas-
mic domains (GST-
 
 
 
9, GST-
 
 
 
5, GST-
 
 
 
4, and GST-
 
 
 
2) to
[
 
35
 
S]Met-labeled SSAT generated by in vitro transcription and
translation. SSAT specifically bound to GST-
 
 
 
9, but not to 
 
 
 
2,
 
 
 
4, 
 
 
 
5, or GST alone (Fig. 1 b). To map the binding site in
SSAT, we generated a series of NH
 
2
 
-terminal and COOH-ter-
minal truncation mutants and found that the COOH-terminal
30 residues (142aa–171aa), including the catalytic site (Cole-
man et al., 1996), were not required for binding, but the 20
amino acids at the NH
 
2
 
 terminus were critical (Fig. 1 c). A dou-
ble mutant that had previously been shown to be catalytically
inactive (R101A/E152K; Coleman et al., 1996) could also bind
the 
 
 
 
9 cytoplasmic domain (Fig. 1 c).
 
SSAT binds to cell surface 
 
 
 
9
 
To determine whether SSAT associates with 
 
 
 
9 in cells, CHO
cells stably expressing either wild-type 
 
 
 
9 or chimeric 
 
 
 
 sub-
units containing the 
 
 
 
9 extracellular and transmembrane do-
mains, fused to the cytoplasmic domains of either 
 
 
 
4 or 
 
 
 
5
(Young et al., 2001), were transfected to stably express SSAT-
Myc. Flow cytometry demonstrated that similar levels of 
 
 
 
9,
 
 
 
9
 
 
 
4, and 
 
 
 
9
 
 
 
5 were expressed on the cell surface (Fig. 2 a).
Lysates from these cell lines were immunoprecipitated with the
anti-
 
 
 
9
 
 
 
1 antibody Y9A2 (Wang et al., 1996) and immuno-
blotted with an anti-Myc antibody. Because endogenously and
heterologously expressed SSAT have been shown to be rapidly
degraded in CHO cells (McCloskey et al., 1999), the concen-
tration of Myc-tagged SSAT was increased by treatment with
Figure 1. SSAT specifically binds to the  9 cytoplasmic domain. (a) Plas-
mid DNA isolated from positive colonies from  9 yeast two-hybrid library
screening were cotransformed into yeast with pAS2-1–containing integrin
 2,  4,  5,  9, or  1 cytoplasmic domain cDNA. 72 h after the transfor-
mation, yeast growth on YPD (-Ade/-His/-Leu/-Trp/ -X-gal) plate was
shown. (b) GST pull-down assays with the  9,  2,  4, and  5 cytoplasmic
domains fused to GST and immobilized on Glutathione Sepharose 4B.
Wild-type SSAT protein was produced by in vitro transcription and transla-
tion (IVTT) in the presence of [
35S]methionine. Bound proteins were sepa-
rated by 15% SDS-PAGE and analyzed by autoradiography. 25% of IVTT
products were also analyzed and showed the same amount of input. (c)
Wild-type and full-length SSAT, NH2-terminal deletion SSAT (21–171),
COOH-terminal deletion mutants (1–161) and (1–141), and enzymatically
inactive (dominant negative [DN]) mutant SSAT (R101A/E152K) proteins
were produced by IVTT, pulled down by GST- 9, and analyzed as in b.
Figure 2. Coimmunoprecipitation of  9 1 and SSAT. (a) Flow cytometric
evaluation of cell surface expression of  9 integrin on  9-,  9 5-, and
 9 4-expressing CHO cells. Open peaks represent fluorescence (FL) of
unstained CHO cells, and shaded peaks represent fluorescence of CHO
stained with the anti- 9 1 antibody Y9A2. (b) CHO cells transfected with
Myc-tagged SSAT were treated with 50  M BE-3-3-3 and immunoprecipi-
tated by protein G–Sepharose coated with the anti- 9 1 antibody Y9A2.
Precipitated proteins (or cell lysates) were separated by SDS-PAGE and
detected with anti-Myc mAb or anti–integrin  1 cytoplasmic domain anti-
serum. (c) Cell surface proteins were labeled with thiol-cleavable biotin,
captured with streptavidin agarose, and eluted by reduction. Eluted pro-
teins were then immunoprecipitated and analyzed as in b.SSAT ENHANCES CELL MIGRATION • CHEN ET AL. 163
the spermine analogue N
1,N
11-bis(ethyl)norspermine tetrahy-
drochloride (BE-3-3-3), which prevents proteosome-mediated
SSAT degradation (Coleman and Pegg, 2001). Western blot-
ting of immunoprecipitates with antiserum against the cyto-
plasmic domain of the integrin  1 subunit confirmed that
similar amounts of  9 1 were precipitated from each lysate.
SSAT was coimmunoprecipitated with full-length  9 1 in cells
treated with BE-3-3-3, but no association with the  9 5 or
 9 4 chimeras could be detected (Fig. 2 b).
To determine whether there is physical interaction between
SSAT and  9 at the cell surface, we labeled cell surface proteins
with a thiol-cleavable amine-reactive biotinylation reagent, Sulfo-
NHS-SS-Biotin. Biotin-labeled cells were lysed, and labeled pro-
teins were captured by streptavidin agarose. Cell surface proteins
were eluted from agarose by reduction and used for coimmuno-
precipitation. SSAT was coimmunoprecipitated with full-length
cell surface  9 1 from cells treated with BE-3-3-3, but no associ-
ation with the  9 5 or  9 4 chimeras could be detected (Fig. 2
c). Thus, SSAT associates with  9 1 at the cell surface.
Increasing SSAT protein concentration 
specifically enhances cell migration 
mediated by the  9 subunit cytoplasmic 
domain
To determine whether the interaction between SSAT and the  9
cytoplasmic domain is critical for the enhancement of cell migra-
tion, we used CHO cells stably expressing wild-type or chimeric
 9 subunits (Young et al., 2001) for cell adhesion and migration
assays on an  9 1-specific substrate in the presence of a range
of concentrations of BE-3-3-3 to increase endogenous levels of
SSAT, and in the presence or absence of the  9 1-blocking anti-
body Y9A2. The  9 1-specific substrate we used (TNfn3RAA)
was a recombinant form of the third fibronectin type III repeat in
chicken tenascin C, in which the normal arginine-glycine-aspar-
tic acid sequence (RGD) had been mutated to arginine-alanine-
alanine (RAA) to prevent interaction with other integrins (Prieto
et al., 1993; Yokosaki et al., 1994, 1998). The expression of
SSAT was induced by BE-3-3-3 in a dose-dependent manner
(Fig. 3 a). In the absence of BE-3-3-3, both the  9 and the  4 cy-
toplasmic domains caused similar enhancement of cell migration
compared with the cytoplasmic domain of  5. However, BE-3-
3-3 caused concentration-dependent enhancement of migration
only in cells expressing wild-type  9 (Fig. 3 b). As we have pre-
viously reported (Young et al., 2001), all three versions of the  9
subunit supported equivalent adhesion to TNfn3RAA, and adhe-
sion was unaffected by BE-3-3-3 treatment in all three cell
lines (Fig. 3 c). As expected, adhesion and migration of all  9-
expressing cells were inhibited by the anti- 9 1 antibody Y9A2.
Migration on the irrelevant substrate, plasma fibronectin, was
similar among all three cell lines and was unaffected by treat-
ment with BE-3-3-3 (Fig. 3 d). Adhesion to fibronectin was also
similar among all three cell lines and was unaffected by BE-3-
Figure 3. Effects of SSAT induction by BE-3-3-3 on adhesion and migra-
tion of  9-expressing CHO cells. (a) CHO cells were treated with BE-3-3-3.
SSAT was detected by Western blotting with rabbit polyclonal anti-SSAT.
Western blot for Crk was used as a control for equal protein loading. (b
and c)  9-,  9 4-, and  9 5-expressing CHO cells were treated with a
range of concentrations of BE-3-3-3 for 24 h and were suspended in se-
rum-free medium. (b) Cells were seeded onto membranes coated with 5
 g/ml TNfn3RAA in the top well of 24-well plates in the presence or ab-
sence of the anti- 9 1 mAb Y9A2. After a 2-h incubation in the presence
of 1% FCS in the bottom well, nonmigrated cells on the top side of the
membrane were removed, and migrated cells on the bottom side were
fixed, stained, and counted. (c) Cells were added to 96-well plates coated
with 5  g/ml TNfn3RAA in the presence or absence of the anti- 9 1
mAb Y9A2. They were allowed to attach for 60 min, and nonadherent
cells were removed by centrifugation. Adherent cells were stained with
crystal violet and quantified by measurement of absorbance at 595 nm.
(d) Migration of  9-,  9 4-, and  9 5-expressing CHO cells was ana-
lyzed on plasma fibronectin (FN; 5  g/ml). All data represent the means
( SEM) of triplicate experiments.JCB • VOLUME 167 • NUMBER 1 • 2004 164
3-3 (unpublished data). These results indicate that the effects of
BE-3-3-3 are specific for  9 1-mediated cell migration and are
dependent on the presence of the  9 cytoplasmic domain.
Confluent CHO cells expressing wild-type  9 or the  9 5
chimera were plated on TNfn3RAA and scratch wounded. Clo-
sure of the wound was quantified by phase-contrast microscopy
as a measure of directed cell migration. Cells expressing the
 9 5 chimera showed markedly slower migration and wound
closure than cells expressing wild-type  9. Wound closure was
accelerated by BE-3-3-3 in cells expressing wild-type  9, but
not in cells expressing the  9 5 chimera (Fig. 4 a). Photomicro-
graphs of the wound edge did not reveal any systematic differ-
ences in cell morphology for cells expressing  9 in the presence
or absence of treatment with BE-3-3-3 (Fig. 4 b).
SSAT-induced enhancement of  9-
dependent cell migration requires the 
catalytic activity of SSAT
Endogenous levels of SSAT are below the level of detection by
existing anti-SSAT antibodies. To confirm the relationship be-
tween the SSAT expression level and  9 1-dependent cell mi-
gration, and to determine whether the effects of SSAT depend
Figure 4. The induction of SSAT by BE-3-3-3 enhances  9-mediated cell
migration. (a) CHO cells stably expressing wild-type  9 or the  9 5 chi-
mera were plated onto dishes coated with 5  g/ml TNfn3RAA, scratch
wounded at confluence in the presence or absence of BE-3-3-3, and al-
lowed to migrate into the wound space for 8 h. The ratio of the final
wound area to the area immediately after scratching is indicated as per-
cent closure. (b) Cells transfected with wild-type  9 were incubated with
or without BE-3-3-3 and fixed 8 h after scratch wounding.
Figure 5. Adhesion and migration of  9-expressing CHO cells trans-
fected with SSAT.  9-expressing CHO cells were transfected with empty
plasmid (Mock), wild-type SSAT (WT), or enzymatically inactive mutant
SSAT (dominant negative [DN]). Cells were treated with or without 50  M
BE-3-3-3 for 24 h. (a) Cell migration on 5  g/ml TNfn3RAA, (b) cell adhe-
sion on 5  g/ml TNfn3RAA, and (c) cell migration on 5  g/ml fibronectin
were assayed and analyzed as described in the Fig. 3 legend. All data
represent the means ( SEM) of triplicate experiments. (d) Western blot
showing level of SSAT protein detection in mock- and SSAT-transfected  9-
expressing CHO cells in the presence or absence of treatment with BE-3-3-3.
Western blot for Crk was used as a control for equal protein loading.SSAT ENHANCES CELL MIGRATION • CHEN ET AL. 165
on catalytic activity, we also performed adhesion and migration
assays in CHO cells stably transfected to express either wild-
type or catalytically inactive (R101A/E152K mutant) c-Myc–
tagged SSAT. In the absence of BE-3-3-3, cells coexpressing
wild-type  9 and exogenous wild-type SSAT demonstrated en-
hancement of cell migration on TNfn3RAA, compared with
cells expressing wild-type  9 alone (Fig. 5 a); cell migration
was further enhanced by treatment with BE-3-3-3. In contrast,
neither treatment with BE-3-3-3 nor overexpression of wild-
type SSAT had any effect on migration in cells expressing the
chimeric subunits composed of the extracellular and transmem-
brane domains of  9 fused to the cytoplasmic domains of  4
( 9 4) or  5 ( 9 5). The relative SSAT protein concentrations
in mock- and SSAT-transfected cells in the presence and ab-
sence of treatment with BE-3-3-3–treated cells are shown in
Fig. 5 d. Expression of catalytically inactive SSAT (Coleman et
al., 1996) did not affect the baseline enhancement of cell migra-
tion in cells expressing wild-type  9, perhaps because the level
of expression was not adequate to effectively compete with that
of endogenous SSAT. However, catalytically inactive SSAT
did not enhance cell migration, and it prevented even the in-
crease in migration caused by BE-3-3-3 in cells expressing
wild-type  9 alone, a result consistent with previous reports that
this construct can function as a dominant negative inhibitor of
Figure 6. Effects of siRNA knockdown on
 9-dependent enhancement of cell migration.
(a)  9-expressing MEFs were transfected with
siRNA-1, siRNA-2, siRNA-3, siRNA-4, and no
siRNA control in 6-well plates. 24 h later,
SSAT mRNA was assayed by quantitative PCR
and expressed as percent basal level (normal-
ized to no siRNA). (b) 50  M BE-3-3-3 was
used to induce the expression of SSAT 24 h af-
ter siRNA transfection, for 24 h. SSAT protein
was detected by Western blot. Western blot
for Crk was used as a control for equal pro-
tein loading. (c and d)  9-,  9 4-, and  9 5-
expressing MEFs were transfected with siRNA-1,
siRNA-2, siRNA-3, siRNA-4, and no siRNA;
24 h later, cells suspended in serum-free me-
dium were used for migration assays without
BE-3-3-3 (c) and with 50  M BE-3-3-3 (d). The
cells were assayed and counted as described
in the Fig. 3 legend.JCB • VOLUME 167 • NUMBER 1 • 2004 166
wild-type SSAT (Coleman et al., 1996). Similar to the previous
experimental results, overexpression of either form of SSAT
had no effect on cell adhesion on TNfn3RAA or on migration
on plasma fibronectin in the presence or absence of BE-3-3-3
(Fig. 5, b and c). These results confirm the specificity of SSAT
for enhancement of  9-dependent cell migration and suggest
that this effect depends on the catalytic activity of SSAT.
Knockdown of endogenous SSAT 
specifically inhibits cell migration 
mediated by the  9 subunit cytoplasmic 
domain
To further investigate the importance of SSAT for  9 1-
dependent enhancement of cell migration, we used RNA inter-
ference to suppress the expression of SSAT in  9-expressing
mouse embryonic fibroblasts (MEFs). MEFs were chosen be-
cause the availability of complete genomic sequence data in the
mouse allows improved design of specific small interfering
RNA (siRNA), and because mouse and human SSAT are virtu-
ally identical. Four 21-nucleotide siRNA segments directed
against the middle (siRNA-1 and siRNA-3) or the 3  end
(siRNA-2 and siRNA-4) of the SSAT transcript were trans-
fected into MEFs that had been stably transfected to express ei-
ther wild-type  9,  9 4, or  9 5, and the cells were examined
24 h later (Young et al., 2001). Real-time PCR showed that
SSAT mRNA was reduced by  75% by siRNA-2, siRNA-3,
and siRNA-4, compared with untransfected cells or cells trans-
fected with siRNA-1 (Fig. 6 a). Because endogenous SSAT
cannot be detected by a polyclonal antibody against SSAT, BE-
3-3-3 was used to induce the expression of SSAT 24 h after
siRNA transfection. The SSAT protein level was decreased by
siRNA-2, siRNA-3, and siRNA-4, compared with untrans-
fected cells or cells transfected with siRNA-1 (Fig. 6 b). Trans-
fection with siRNA-2, siRNA-3, and siRNA-4 decreased the
cell migration on TNfn3RAA of cells expressing wild-type  9
to the level seen for cells transfected with the  9 5 chimera,
but had no effect on the migration of cells expressing  9 4 or
 9 5 (Fig. 6 c). The enhancement of  9-dependent cell migra-
Figure 7. Rescue of siRNA knockdown of
hamster SSAT by overexpression of human
wild-type SSAT cDNA in CHO cells. (a and b)
 9-expressing CHO cells stably expressing ei-
ther empty vector or wild-type human SSAT
(SSAT(WT)) were transfected with siRNA-1
(nonfunctional), siRNA-3, and siRNA-4 in
6-well plates. (a) 24 h later, hamster SSAT
mRNA was assayed by quantitative PCR and
expressed as percent basal level (normalized
to siRNA-1). (b) Human SSAT mRNA was as-
sayed by quantitative PCR and expressed as
percent basal level (normalized to siRNA-1).
(c) BE-3-3-3 was used to stabilize SSAT 24 h
after transfection with nonfunctional siRNA (1)
or two functional siRNAs (3 and 4) in CHO
cells stably transfected with empty plasmid
(CHO- 9-Mock) or wild-type human SSAT
(CHO- 9-SSAT(WT)). SSAT protein was de-
tected by Western blot. Western blot for Crk
was used as a control for equal protein load-
ing. (d)  9- or  9 5-expressing CHO cells
with or without human SSAT expression
were transfected with siRNA-1, siRNA-3, and
siRNA-4; 24 h later, cells were suspended in
serum-free medium and used for migration as-
says without BE-3-3-3 (0  M) or with BE-3-3-3
(50  M), as described in the Fig. 3 legend.SSAT ENHANCES CELL MIGRATION • CHEN ET AL. 167
tion by BE-3-3-3 was also decreased by siRNA transfection
(Fig. 6 d). None of these treatments had any effect on cell adhe-
sion on TNfn3RAA or on cell migration on fibronectin in any
cell type (unpublished data). These results further support the
concept that endogenous levels of SSAT play an important role
in  9-dependent enhancement of cell migration.
The target sequences of the functional siRNA-3 and
siRNA-4 are the same in mouse and hamster SSAT cDNA.
Therefore, we used these two siRNAs to inhibit the expression
of endogenous SSAT in CHO cells. Both mRNA and protein
concentrations of hamster SSAT were substantially reduced by
each siRNA (Fig. 7, a and c). However, the sequence of human
SSAT is different from the mouse and hamster sequences in
the regions targeted by each of these siRNAs. Thus, neither
siRNA-3 nor siRNA-4 affects the mRNA or protein concentra-
tion in cells transfected to express human SSAT (Fig. 7, b and
c). In CHO cells that only express endogenous hamster SSAT,
as in MEFs, the enhancement of  9-dependent cell migration
by BE-3-3-3 was decreased by siRNA transfection (Fig. 7 d).
However,   9-dependent enhancement of cell migration was
not inhibited by siRNA-targeting mouse (and hamster) SSAT
in CHO cells overexpressing human SSAT (Fig. 7 d). This re-
constitution of  9-dependent enhancement of cell migration in
siRNA-treated CHO cells with human SSAT that is resistant to
these siRNAs suggests that the effects of the siRNAs tested are
likely specifically due to the knockdown of SSAT.
SSAT specifically enhances  9-mediated 
cell migration in HMVEC that express 
endogenous  9 1
To further investigate the importance of SSAT for endogenous
 9 1-dependent enhancement of cell migration in untrans-
fected cells, we tested the expression of integrin  9 1 on the
cell surface of human microvascular endothelial cells (HM-
VEC) by flow cytometry (Fig. 8 a). The expression of SSAT in
these cells was induced by BE-3-3-3 and inhibited by siRNA
Figure 8. Effects of siRNA knockdown and BE-3-3-3 on
endogenous  9-dependent HMVEC migration. (a) Flow
cytometric evaluation of cell surface expression of  9 in-
tegrin on HMVEC. Open peaks represent unstained cells,
and shaded peaks represent cells stained with the anti-
 9 1 antibody Y9A2. (b) HMVEC were transfected with
siRNA-A, siRNA-B, and no siRNA control in 6-well
plates. 24 h later, SSAT mRNA was assayed by quantita-
tive PCR and expressed as percent basal levels (normal-
ized to no siRNA). (c) 50  M BE-3-3-3 was used to in-
duce the expression of SSAT 24 h after siRNA
transfection, for 24 h. SSAT protein concentration was
assessed by Western blot. Western blot for Crk was used
as a control for equal protein loading. (d and e) HMVEC
were transfected with siRNA-A, siRNA-B, and no siRNA,
and 24 h later, cells were or were not treated with BE-3-
3-3 (50  M) for 24 h. After treatment with BE-3-3-3, cells
were suspended in serum-free medium and were used for
migration assays on 5  g/ml TNfn3RAA (d) or on 5  g/
ml fibronectin (FN; e), as described in the Fig. 3 legend.
All data represent the means ( SEM) of triplicate experi-
ments.JCB • VOLUME 167 • NUMBER 1 • 2004 168
directed against human SSAT. Two siRNAs were evaluated,
and only one (siRNA-A) consistently inhibited SSAT mRNA
concentrations in untreated cells (Fig. 8 b) and dramatically re-
duced SSAT protein levels in BE-3-3-3–treated cells (Fig. 8 c).
Induction of SSAT increased HMVEC migration on the  9 1-
specific ligand, TNfn3RAA. Inhibition of SSAT by functional
siRNA specifically decreased cell migration on TNfn3RAA
(Fig. 8 d). Neither BE-3-3-3 nor siRNA against human SSAT
had any effect on cell migration on the  9 1-irrelevant ligand,
plasma fibronectin (Fig. 8 e). These results demonstrate that
the expression level of SSAT specifically affects  9 1-depen-
dent cell migration in cells that endogenously express  9 1.
Discussion
We have previously demonstrated that the integrin  9 1 medi-
ates enhancement of cell migration (Taooka et al., 1999; Young
et al., 2001). As with the closely related integrin  4 1, this me-
diation depends on sequences within the   subunit cytoplasmic
domain. However, in contrast with the mechanism used by  4,
 9-dependent enhancement of migration does not require the
adapter protein paxillin (Young et al., 2001). We now show that
the acetyltransferase SSAT specifically and directly binds to
the  9 cytoplasmic domain, that increased levels of SSAT fur-
ther accelerate cell migration only in cells expressing wild-type
 9 and only on  9 1-specific substrate, and that decreased lev-
els of SSAT only decrease cell migration under the same cir-
cumstances. Furthermore, these effects of SSAT appear to re-
quire catalytic activity. Together, these results strongly suggest
that catalytically active SSAT is a critical component of the
pathway by which the integrin  9 1 enhances cell migration,
and that this pathway is highly specific for this integrin.
As we have previously reported (Young et al., 2001),
 9 1 (containing the complete  9 cytoplasmic domain) is dif-
fusely expressed on the cell surface and does not localize to fo-
cal adhesion structures, even in cells plated on specific ligands
(e.g., TNfn3RAA). Although we are unable to detect endoge-
nous SSAT with available reagents, heterologously expressed
Myc- or RFP-tagged SSAT is diffusely expressed throughout
the cytoplasm and nucleus (unpublished data). Thus, although
both proteins can be seen along the cell membrane, we have not
been able to infer “colocalization” from immunostaining ex-
periments. Nonetheless, the broad expression pattern of each
protein at least suggests that it is feasible for them to make con-
tact in intact cells. In vivo, SSAT is ubiquitously expressed,
whereas  9 1 expression is restricted to subsets of epithelial
cells, muscle cells (Palmer et al., 1993), leukocytes (Taooka et
al., 1999), and endothelial cells. Thus, SSAT is clearly ex-
pressed in cells that do not express  9 1, but all  9 1-express-
ing cells are likely to express SSAT.
Over the past several years, much has been learned about
the common pathways by which ligated integrins activate cyto-
plasmic signals (outside-in signaling) and by which cytoplasmic
signals affect the affinity and avidity of integrins (inside-out sig-
naling). However, the divergent phenotypes of mice expressing
null mutations of individual integrin subunits, and the divergent
effects of specific integrins on cell behavior, make it clear that
the signaling pathways used by integrins can be highly specific.
In this paper, we describe a novel example of integrin specificity
that appears to be critical for the best-characterized cellular
function of the  9 1 integrin, acceleration of cell migration.
The oxidative catabolism of the higher order polyamines,
spermidine and spermine, is accomplished by the concerted ac-
tion of two different enzymes, SSAT and polyamine oxidase
(PAO). Cytosolic SSAT N
1 acetylates both spermidine and
spermine, which then serve as substrates for peroxisomal
PAO (Holtta, 1977). Because PAO strongly prefers acetylated
polyamines to unmodified polyamines as its substrates, SSAT is
generally considered the rate-controlling enzyme in the back
conversion of the higher order polyamines, spermidine and sper-
mine, to the lower order polyamine, putrescine (Casero and
Pegg, 1993). Thus far, spermine and spermidine are the only
physiological substrates that have been identified for SSAT.
Therefore, it is tempting to speculate that SSAT enhances  9 1-
dependent cell migration by local effects on polyamines. Indeed,
previous studies have implicated polyamines in the regulation of
cell migration, although polyamines’ precise mechanisms of ac-
tion in this process have been obscured (Johnson et al., 2002;
Ray et al., 2003). Depletion of polyamines by treatment with
DFMO, a drug that blocks the enzyme ornithine decarboxylase
responsible for conversion of ornithine to putrescine, has been
shown to globally inhibit cell migration and reduce cellular ac-
tivity of the small GTPase rac1, a well-established mediator of
cell migration (Johnson et al., 2002; Ray et al., 2003). Thus, it is
conceivable that SSAT-mediated modulation of local polyamine
concentrations enhances local rac1 activity to enhance cell mi-
gration. However, an equally plausible hypothesis is that SSAT
is involved in acetylating other unknown substrates whose
acetylation affects their role in enhancing cell migration.
The  9 1 integrin is expressed on several cells for which
migration is critical for function. For example, this integrin is ex-
pressed on neutrophils and monocytes and has been shown to
play an important role in neutrophil emigration across activated
endothelial cells (Taooka et al., 1999). Transendothelial migra-
tion appears to depend on binding of  9 1 to VCAM-1, an in-
ducible ligand expressed on endothelial cells at sites of infection,
tissue injury, and inflammation. Several other  9 1 ligands have
been identified; many of them, including tenascin C (Yokosaki
et al., 1994), osteopontin (Smith et al., 1996; Yokosaki et al.,
1999), tissue fibronectin (Liao et al., 2002), and the coagulation
proteins von Willebrand factor and factor XIII (Takahashi et al.,
2000), are highly enriched in injured and inflamed tissues. Thus,
 9 1 is likely to play an important role in both leukocyte emi-
gration from the vasculature and leukocyte migration through
the extravascular space at sites of injury, infection, or chronic in-
flammation. Furthermore, mice expressing a null mutation of the
 9 subunit demonstrate defects in development of lymphatic
vessels (Huang et al., 2000), suggesting a possible role for  9 1
in the migration of lymphatic endothelial cells required for nor-
mal lymphatic development. Thus, our identification of SSAT as
a critical effector molecule in  9 1-dependent cell migration
provides a new target for intervention in disorders that are char-
acterized by excessive leukocyte emigration as well as for modu-
lation of the migration of other  9 1-expressing cells.SSAT ENHANCES CELL MIGRATION • CHEN ET AL. 169
Materials and methods
Reagents
Mouse mAb (Y9A2) raised against human  9 1 (Wang et al., 1996) was
prepared as described previously. mAb 9B11 against the Myc tag was
purchased from Cell Signaling Technology. BE-3-3-3 was purchased from
Tocris Cookson Inc. Polyclonal antibody against integrin  1 was pur-
chased from CHEMICON International. Anti-Crk was purchased from Up-
state Biotechnology. Polyclonal anti-SSAT antibody was prepared as de-
scribed previously (Casero et al., 1991).
Yeast two-hybrid screening
The yeast MATCHMAKER two-hybrid system (CLONTECH Laboratories, Inc.)
was used for a library screen. In brief,  9,  2,  4,  5, and  1 cytoplasmic
domains (aa 2883–3053 for  9) were amplified by PCR and cloned into
the Gal4-DNA–binding domain (Gal4-DB) vector (pAS2-1) to screen a li-
brary of human leukocyte cDNAs fused to the Gal4-DNA activation domain
(Gal4-DA) vector (pACT2). AH109 were used as the host strain. Yeast two-
hybrid library screening was performed according to the MATCHMAKER
manual on plates lacking adenine, histidine, leucine, and tryptophan. Posi-
tive interactions were confirmed by  -galactosidase expression on  -X-Gal.
Expression and purification of GST fusion proteins
GST fusion proteins containing the  9,  2,  4, and  5 cytoplasmic do-
mains were generated by cloning the PCR-amplified sequences into the
bacterial expression plasmid pGEX-4T-1 (Amersham Biosciences) and
transforming BL21-Gold bacteria (Stratagene). Transformed cells were cul-
tured in 300 ml of YT medium in the presence of 0.1 mM isopropyl- -D-1-
thiogalactopyranoside (Sigma-Aldrich), and GST fusion proteins were pu-
rified on glutathione-Sepharose by B-PER GST Fusion Protein Purification
Kit (Pierce Chemical Co.).
In vitro transcription and translation and protein binding assays
In vitro transcription and translation experiments were done with the T7
RNA polymerase transcription/translation systems, using rabbit reticulo-
cyte lysate (Promega) and L-[
35S]methionine (AG1094; Amersham Bio-
sciences) to produce 
35S-labeled proteins according to the manufacturer’s
recommendations. Plasmids containing full-length, truncated, or mutant
forms of SSAT in pBluescript SK were used as templates. 0.8 nmol of the
appropriate GST fusion protein was mixed with 40  l of the in vitro trans-
lation reaction above and 50  l of glutathione-Sepharose beads, and
then incubated in binding buffer (PBS with 1% Triton X-100) at 4 C for
2 h. The beads were washed five times in 1 ml of binding buffer and re-
suspended in 25  l Laemmli sample buffer and heated at 95 C for 5 min.
Bound proteins were separated by SDS-PAGE (15%) under reducing con-
ditions. Gels were fixed in 50% methanol and 10% acetic acid for 30
min, soaked in a fluorographic reagent (Amplify; Amersham Biosciences),
dried, and developed by autoradiography.
Generation of stable cell lines
Integrin  9-,  9 4-, and  9 5-expressing CHO cells and MEFs were gener-
ated in our lab previously (Young et al., 2001). Transfected cells were ana-
lyzed for expression of  9,  9 4, and  9 5 integrins by flow cytometry
with Y9A2. Fluorescence-activated cell sorting was performed to isolate het-
erogeneous populations of cells expressing high levels of  9 1 integrin on
their cell surface (Yokosaki et al., 1998). All cell lines continuously expressed
high surface levels of  9 1 as determined by flow cytometry with Y9A2.
Full-length SSAT cDNAs were amplified by forward primer (GCA-
GCGGATCCCCGCCATGGCTAAATTCGTGATCCGCCCAGCCACTGC-
GCCGACT) and reverse primer (CGTACCTCGAGTCAATTCAGATC-
CTCTTCTGAGATGAGTTTTTGTTCCTCCTCTGTTGCCATTTTTA) to add a
c-Myc tag to the COOH terminus using either wild-type SSAT or the double
mutant (R101A/E152K) in pBluescript SK as template (Coleman et al.,
1995). The PCR products were digested by EcoRI and XhoI and cloned into
pcDNA3.1/Hygro( ) (Invitrogen). Expression constructs were confirmed by
restriction digestion and sequencing. Integrin  9-,  9 4-, and  9 5-
expressing CHO cells were used for transfection. Stable clones were ob-
tained by dilution subcloning and characterized by Western blotting. These
double transfectants were maintained in medium containing 250  g/ml
G418 and 50  g/ml hygromycin.
Coimmunoprecipitation and Western blot analysis
CHO cell lines expressing different chimeric  9 1 integrins were lysed on
ice for 30 min in an immunoprecipitation buffer (20 mM Tris-HCl, pH 7.4,
150 mM NaCl, 10 mM EDTA, 10 mM benzamidine-HCI, 0.02% sodium
azide, 1% Triton X-100, 0.05% Tween 20, 2 mM PMSF, 5  g/ml aprotinin,
and 5  g/ml leupeptin). Lysates were clarified by centrifuging at 16,000 g
for 20 min at 4 C, and then were incubated with protein G–Sepharose
coated with Y9A2 at 4 C overnight. The beads were washed with the same
buffer five times, and precipitated polypeptides were extracted in Laemmli
sample buffer, separated by SDS-PAGE under reducing conditions, probed
with anti-Myc mAb, and detected by ECL (Amersham Biosciences).
Cell surface protein biotinylation and coimmunoprecipitation
To determine whether there is interaction between SSAT and cell surface
 9 1, labeling of surface proteins was performed using the lysine-directed,
membrane-impermeant biotinylating reagent sulfo-NHS-SS-biotin (Pierce
Chemical Co.). Cells were washed four times with PBS at 4 C and incu-
bated with 1.5 mg/ml sulfo-NHS-SS-biotin in PBS for 30 min at 4 C. After
the sulfo-NHS-SS-biotin incubation, cells were washed twice with 100 mM
glycine in PBS at 4 C and incubated for 20 min at 4 C in glycine/PBS. The
glycine buffer was removed, lysis buffer (20 mM Tris-HCl, pH 7.4, 150
mM NaCl, 10 mM EDTA, 1% Triton X-100, 0.05% Tween 20, 1  pro-
tease inhibitor cocktail) was applied, and the mixture was shaken for 30
min at 4 C. The supernatants were cleared of insoluble material by pellet-
ing at 15,000 rpm for 20 min at 4 C. ImmunoPure-immobilized streptavi-
din beads (Pierce Chemical Co.) were washed three times with 100 mM
glycine/PBS and four times with lysis buffer, and finally were resuspended
in lysis buffer. 210  l of bead/lysis buffer slurry was added to 750  l of
supernatant, and the mixture was gently mixed for 1 h at room tempera-
ture. After incubation, the streptavidin beads were washed four times with
lysis buffer and the biotinylated proteins were eluted from the beads with
lysis buffer containing 50 mM DTT. Eluted samples were used for coimmu-
noprecipitation as described in the previous paragraph.
siRNA construction and transfection
siRNAs to mouse SSAT were designed with 3 -overhanging thymidine
dimers as described previously (Elbashir et al., 2001). Target se-
quences were aligned to the mouse genome database in a BLAST search
(www.ncbi.nlm.nih.gov/blast) to eliminate those with significant similar-
ity to other genes. Web-based siRNA design software from Ambion
(www.ambion.com/techlib/misc/siRNA_finder.html) was used for select-
ing siRNA sequences. Four siRNAs (siRNA-1, UCUAAGCCAGGUUGC-
CAUGTT; siRNA-2, AAGAAGAGGUGCUUCGGAUTT; siRNA-3, CAC-
CCCUUCUACCACUGCCTT; and siRNA-4, AAAUGGCAGCAGAGG-
AGUGTT) for mouse SSAT and two siRNAs (siRNA-A, UGGCUAAA-
UUCGUGAUCCGTT; and siRNA-B, GAUGGUUUUGGAGAGCACCTT)
for human SSAT were synthesized (Proligo) and used for transfection with
the siPORT Amine Transfection Agent (Ambion). In brief, MEF cells or
HMVEC were grown to 50–70% confluence in complete medium without
antibiotics in 6-well plates. Cells were washed with serum-free medium. 10
 l SiPORT Amine was added to Opti-MEM I (Invitrogen) medium for a final
complexing volume of 200  l, and the mixture was vortexed and then incu-
bated at room temperature for 10–30 min. 1.25  l of 20  M siRNA was
added, mixed gently, and incubated for 15 min. This mixture was added
dropwise to cells in a volume of 800  l Opti-MEM I.
Flow cytometry
Cultured cells were harvested by trypsinization and rinsed with PBS. Non-
specific binding was blocked with normal goat serum at 4 C for 10 min.
Cells were then incubated with a primary antibody (Y9A2) for 20 min at
4 C, followed by a secondary goat anti–mouse antibody conjugated with
phycoerythrin (CHEMICON International). Between incubations, cells
were washed twice with PBS. The stained cells were resuspended in 100
 l PBS, and fluorescence was quantified on 5,000 cells with a FACScan
flow cytometer (Becton Dickinson).
Cell adhesion assays
The wells of nontissue culture–treated 96-well microliter plates (Nunc)
were coated by incubation with 100  l TNfn3RAA for 1 h at 37 C. After
incubation, wells were washed with PBS and then blocked with 1% BSA in
DME at 37 C for 30 min. Control wells were filled with 1% BSA in DME.
The cells were detached with 2.5 ml of trypsin solution (Sigma-Aldrich) fol-
lowed by 2.5 ml of trypsin-neutralizing solution (Sigma-Aldrich), washed
once in DME, and resuspended in DME at 5   10
5 cells/ml in the pres-
ence or absence of 50  g/ml Y9A2 for 20 min at 4 C before plating.
Plates were centrifuged (top side up) at 10 g for 5 min before incubation
for 1 h at 37 C in humidified 5% CO2. Nonadherent cells were then re-
moved by centrifugation (top side down) at 48 g for 5 min. Attached cells
were fixed and stained in 40  l of a 1% formaldehyde, 0.5% crystal vio-
let, and 20% methanol solution for 30 min; then, the wells were washed
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ated after solubilization in 40  l of 2% Triton X-100 by measuring the ab-
sorbance at 595 nm in a microplate reader (Bio-Rad Laboratories). All de-
terminations were performed in triplicate, and the data represent the
means   SEM for a minimum of three experiments.
Cell migration assays
For chemotactic migration assays, 24-well Transwell plates (Costar) were
used. The lower sides of the Transwell filters (6.5-mm diam, pore size 8.0
 m) were coated with TNfn3RAA dissolved in 250  l DME for 60 min at
37 C. After incubation with TNfn3RAA, the filters were washed by adding
100  l PBS to the top well and 500  l PBS to the bottom well. After being
washed twice, the filters were blocked with 1% BSA in DME for 30 min and
washed again in PBS. Cells were detached as described in the previous
paragraph and resuspended in DME at 5   10
5 cells/ml. Migration and
adhesion assays were performed simultaneously, and the cells from the
same dishes were used for both assays. Cells were incubated for 20 min on
ice with or without 50  g/ml of Y9A2, and then 100  l (50,000 cells)
were loaded in each chamber. Each chamber was inserted in a well con-
taining 600  l DME supplemented with 1% FCS to serve as a chemoattrac-
tant and incubated at 37 C in humidified 5% CO2 for 2 h (CHO cells) or
3 h (MEF cells). The medium was then aspirated and the filters were washed
once with PBS. Cells on the bottom of the filters were fixed for 20 min in
500  l of DifQuik fixative (Fisher Scientific), and the nonmigrated cells on
the top of the filter were gently removed. Filters were allowed to completely
dry, stained with DifQuik, washed in running distilled H2O, and allowed to
destain in distilled H2O for 1 h. Filters were air dried (for  3 h), removed
from the chamber with a scalpel, and mounted on glass slides with a Perma-
mount/xylene solution (Fisher Scientific). Migrated cells were counted under
a 25  objective with the use of a gridded eyepiece (reticule). 10 high-pow-
ered fields (HPF) per slide were counted, the average was taken, and the
number of migrated cells was expressed as migrated cells per 10 HPF. The
data represent the means   SEM for a minimum of three experiments.
Scratch wound assay
Tissue culture dishes were coated with 5  g/ml GST-TNfn3RAA overnight
at 4 C. Cells were suspended with trypsin/EDTA and plated onto coated
dishes at a density of 10
6 cells/35-mm dish. After 2 h, cell cultures were
scratched with a single pass of a pipette tip and incubated at 37 C for 8 h.
In some cases, culture media were supplemented with 50  M BE-3-3-3. Cul-
tures were washed twice with PBS, fixed in 3.7% formaldehyde for 10 min,
and photographed. Cells were viewed on an inverted microscope (model
PE300; Nikon) using Nikon objective lenses (10 /0.30; 20 /0.45). Im-
ages were processed by Openlab 2.2.5 software (Improvision) and an
ICCD digital camera (model C4742-95; Hamamatsu Photonics) at room
temperature, and were arranged and labeled using Adobe Photoshop.
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